XML 62 R10.htm IDEA: XBRL DOCUMENT

INVENTORIES

3 Months Ended

Mar. 31, 2014

At March 31, 2014 and December 31, 2013, inventories consisted of the following (in thousands):



	March 31, 2014		December 31, 2013
Raw materials	$	12,259	$	11,587
Work-in-process	22,256		22,139
Finished goods	28,856		30,305
Total	$	63,371	$	64,031

Short-term portion	$	57,506	$	58,059
Long-term portion	$	5,865	$	5,972

Inventory at March 31, 2014 includes $1.8 million, net of fair value step-up in basis that was recognized when the Company acquired eBioscience in 2012. Amortization expense related to the fair value step-up during the three months ended March 31, 2014 and 2013 was $2.9 million and $4.6 million, respectively.

- Definition

The entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.

+ References+ Details